Literature DB >> 20024966

Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride.

Peih-Jeng Jiang1, Sarika Patel, Uwe Gbureck, Ryan Caley, Liam M Grover.   

Abstract

A number of calcium phosphate materials have been investigated as drug release matrices for the prophylactic treatment of implant-related osteomyelitis. However, some studies have shown the influence of processing on the efficacy of the delivered drug. The objective of this study was to evaluate the influence of pH during processing on the efficacy of vancomycin hydrochloride (VH) against Staphylococcus aureus. VH was loaded into a brushite cement (CaHPO(4).2H(2)O; pH 2.4); a hydroxyapatite cement (Ca(10)(PO(4))(6)OH(2); pH 9.4); and an apatite xerogel (pH 7.4). The pH of the material during processing had a significant influence on the mechanism of release from the cement. VH released from the apatite cement (pH 9.4) was not released in accordance with the Higuchi model. In addition to affecting release, the basic pH was shown to diminish the antibacterial potency of the released VH. Despite exceeding the minimum inhibitory concentration, the eluent from the apatite cement was ineffective against a culture of S. aureus. The findings of this study reinforce the importance of evaluating not only the release of the drug from the material matrix but also the antibacterial potency of the released drug.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20024966     DOI: 10.1002/jbm.b.31557

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  6 in total

1.  Reducing Staphylococcus aureus biofilm formation on stainless steel 316L using functionalized self-assembled monolayers.

Authors:  Kristen M Kruszewski; Laura Nistico; Mark J Longwell; Matthew J Hynes; Joshua A Maurer; Luanne Hall-Stoodley; Ellen S Gawalt
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-01-18       Impact factor: 7.328

2.  Composition and properties of silver-containing calcium carbonate-calcium phosphate bone cement.

Authors:  Sylvaine Jacquart; Robin Siadous; Christel Henocq-Pigasse; Reine Bareille; Christine Roques; Christian Rey; Christèle Combes
Journal:  J Mater Sci Mater Med       Date:  2013-07-28       Impact factor: 3.896

3.  A novel injectable borate bioactive glass cement for local delivery of vancomycin to cure osteomyelitis and regenerate bone.

Authors:  Xu Cui; Cunju Zhao; Yifei Gu; Le Li; Hui Wang; Wenhai Huang; Nai Zhou; Deping Wang; Yi Zhu; Jun Xu; Shihua Luo; Changqing Zhang; Mohamed N Rahaman
Journal:  J Mater Sci Mater Med       Date:  2014-01-30       Impact factor: 3.896

4.  Gentamicin loading of calcium phosphate implants: implications for cranioplasty.

Authors:  Jimmy Sundblom; Sara Gallinetti; Ulrik Birgersson; Håkan Engqvist; Lars Kihlström
Journal:  Acta Neurochir (Wien)       Date:  2019-04-30       Impact factor: 2.216

5.  A new type of biphasic calcium phosphate cement as a gentamicin carrier for osteomyelitis.

Authors:  Wen-Yu Su; Yu-Chun Chen; Feng-Huei Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-09       Impact factor: 2.629

6.  Suitability of Biomorphic Silicon Carbide Ceramics as Drug Delivery Systems against Bacterial Biofilms.

Authors:  P Díaz-Rodríguez; A Pérez-Estévez; R Seoane; P González; J Serra; M Landin
Journal:  ISRN Pharm       Date:  2013-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.